MASH Comorbidity Index

1 paper1 finding

Associations

Overall mortality

upin humans1HR 2.43

1 study

MASH Comorbidity Index predicts overall mortality in humans (MaSH-CI 2+ versus 0: HR 2.43, 95% CI 1.70–3.47).
“Higher MaSH-CI predicted inferior OS (1 vs. 0: HR = 1.59 [1.27-1.98]; 2+ vs. 0: HR = 2.43 [1.70-3.47]).”
HumansLarge B-cell lymphoma; MaSH-CI 2+ versus 0n = 539
Other illnesses linked to poorer lymphoma survival at 80 and over
Clinical lymphoma, myeloma & leukemia23 Sep 2026

1 in 12 months

Clinical Lymphoma, Myeloma & Leukemia5 h